WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 15-July-2017 (data as of 11-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 52
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 62

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 429  428  426  423  421  397  364  333 
Births
Surviving infants
Pop. less than 5 years 21  21  21  21  21  25  27  29 
Pop. less than 15 years 62  62  62  62  62  79  85  79 
Female 15-49 years 96  96  96  96  96  97  93  90 

Number of reported cases

(Click for retrospective incidence data for Malta)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  14 
Mumps
ChartChart
  386 
Pertussis
ChartChart
  106 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Malta)
Vaccine year result method % card seen                                                
BCG          87  92  93  77 
DTP1          97  98  99*  99*  99*  97 
DTP3          97  97  99  99  99  94  63 
DTP4          98  98  90 
IPV1          97  98  99* 
HepB_BD         
HepB3          97  95  90  94  93 
Hib3          97  97  99  99  99  93 
JapEnc         
MCV1          93  89  98  99  93  74  80 
MCV2          86  91  94  88  91 
MenA         
PCV1         
PCV2         
PCV3         
Pol3          97  97  99  99  99  94  86 
Rota1         
RotaC         
RCV1          93  89  98  93 
TT2plus          86 
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Malta)
BCG
  77 
DTP1
  97  98  99  99  99  97  84 
DTP3
  97  97  99  99  99  94  63 
HepB3
  97  95  90  94  93 
HepB_BD
 
Hib3
  97  97  99  99  99  93 
MCV1
  93  89  98  99  93  74  80 
MCV2
  86  91  94  88  91 
PCV3
 
Pol3
  97  97  99  99  99  94  86 
RCV1
  93  89  98  99  93  74  80 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes High risk group parents
DTaPHibIPV 6 weeks; 3, 4, 18 months; Yes
HepB_Pediatric 12, 13, 18 months; Yes
HPV 12 years; +6 months; Yes
Influenza_Adult Yes elderly and health care workers, adults with chronic diseases and other risk groups
Influenza_Pediatric < 5 years; Yes and children with chronic diseases
MMR 13 months; 3-4 years; Yes
TdIPV 14-16 years; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  No  Yes  Yes  Yes 
What years does the MYP cover? number         2012-2015  2011-2013  2010-2012 
Nº of districts with microplans that include activities to raise immunization coverage number         NA 

System performance

Total Nº districts in country number    
Nº districts with DTP3 coverage >=80% number        
% of districts with DTP3 coverage >=80% From 0 to 100%         100  100   
Nº districts with measles (MCV1) coverage >=95% number          
% of districts with MCV1 coverage >=95% From 0 to 100%          

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  No  No  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100  100       

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.